Search clinical trials for: RPF

Total 28 results

National Cancer Institute (NCI)

Not yet recruiting

Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

Breast Carcinoma | Breast Ductal Carcinoma In Situ | Breast Lobular Carcinoma In Situ | Breast Atypical Hyperplasia

United States
National Cancer Institute (NCI)

Not yet recruiting

Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer

Breast Carcinoma | Breast Ductal Carcinoma In Situ | Breast Lobular Carcinoma In Situ | Breast Atypical Hyperplasia

United States
Novartis Pharmaceuticals

Recruiting

A Study Evaluating [177Lu]Lu-PSMA-617 vs. a Change of Androgen Receptor-directed Therapy in Taxane Treatment Naive Chinese Male Patients With Progressive Metastatic Castrate Resistant Prostate Cancer

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

China
Peking University International Hospital

Recruiting

Study of Sirolimus in Idiopathic Retroperitoneal Fibrosis

Retroperitoneal Fibrosis

China
University of Vermont
Duke University

Recruiting

MitoQ for the Treatment of Metabolic Dysfunction in Asthma (MIMDA)

Obesity | Asthma

United States
Queen Mary University of London

Recruiting

Different Surgical Modalities in the Treatment of Periodontitis

Chronic Periodontitis

United Kingdom
Novartis Pharmaceuticals
Alliance Foundation Trials, LLC.; RTOG Foundation, Inc.

Active, not recruiting

An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With SoC, Versus SoC Alone, in Adult Male Patients With mHSPC (PSMAddition)

Prostatic Neoplasms

United States, China, Canada, Spain, United Kingdom, Belgium, Japan, Taiwan, Germany, Singapore, Austria, Netherlands, Korea, Republic of, France, Switzerland, Denmark, Sweden, Poland, Czechia
Novartis Pharmaceuticals

Active, not recruiting

177Lu-PSMA-617 vs. Androgen Receptor-directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer (PSMAfore)

Prostatic Neoplasms

Belgium, Canada, Spain, Germany, Austria, Netherlands, United Kingdom, United States, France, Switzerland, Sweden, Slovakia, Poland, Czechia
Indiana University
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...

Active, not recruiting

Physiological Phenotyping of Respiratory Outcomes in Infants Born Premature (P3)

Premature Lungs

United States
Queen Mary University of London

Active, not recruiting

Imaging Analysis Following Periodontal Surgery

Periodontitis | Healing Wound

United Kingdom
DePuy Orthopaedics

Completed

Does Implant Design Improve Postoperative Flexion?

Non-inflammatory Arthritis

United States
Takeda

Completed

Study of TAK-672 in Participants With Acquired Hemophilia A

Acquired Hemophilia A

Japan
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

Prospective and Retrospective, Non-interventional Study to Evaluate the Safety and Effectiveness of Obizur in Real-life Practice

Acquired Hemophilia A

United States, Italy, United Kingdom, Germany, Austria, Netherlands, France
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Terminated

BAX 802 in CHA With Inhibitors (CHAWI)

Hemophilia A

Netherlands, Spain, Italy, Turkey, Bulgaria, United States, Canada, Germany, Norway, Poland, Russian Federation, South Africa
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

Post-Marketing Non-Interventional Safety Evaluation of Obizur in the Treatment of Bleeding Episodes for Patients With Acquired Hemophilia A

Acquired Hemophilia A

United States
University of Florida
American Society of Nephrology

Withdrawn

Severe Sepsis in Children - IMPRESS-C (IMPRESS-C)

Hypertension | Chronic Kidney Disease | Acute Kidney Injury

United States
University of Florida
American Society of Nephrology

Withdrawn

Impact of Pediatric Acute Renal Injury in Severe Sepsis in Young Adults (IMPRESS-YA)

Hypertension | Chronic Kidney Disease | Acute Kidney Injury
Regional Hospital Holstebro

Completed

Effect of Tolvaptan on Renal Plasma Flow (RPF) and Glomerular Filtration Rate (GFR) in ADPKD (POLY)

Polycystic Kidney, Autosomal Dominant

Denmark
Stiftung Institut fuer Herzinfarktforschung

Completed

German TAVI-Register (TAVI)

Aortic Valve Stenosis | Aortic Valve Insufficiency

Germany
DePuy International

Terminated

A Study to Compare the Press Fit Condylar (P.F.C.) Sigma Rotating-platform High-flexion (RP-F) Versus the Press Fit Condylar (P.F.C.) Sigma Rotating-platform (RP) Knee Implants

Knee Osteoarthritis

Spain, United Kingdom
Carol Fabian, MD
BTR Group

Completed

Modulation of Breast Cancer Risk Biomarkers by High Dose Vitamin D

Breast Cancer

United States
DePuy International

Terminated

Long-term Study of The Press Fit Condylar (P.F.C.) Sigma Total Knee Replacement System

Knee Osteoarthritis

United Kingdom
University of Kansas

Completed

Effects of Controlled Ovarian Hyperstimulation (COH) With Letrozole and Gonadotropin

Breast Cancer | Infertility

United States
Dana-Farber Cancer Institute

Completed

RPFNA Assessment of Exercise Effect in Breast Cancer

Breast Cancer

United States
Seoul National University Hospital

Completed

Comparison of the Tibiofemoral Rotational Alignment After Mobile and Fixed Bearing Total Knee Arthroplasty

Osteoarthritis
Regional Hospital Holstebro

Completed

Short Term Effects of HMG-CoA Reductase Inhibition (Atorvastatin)on Renal Hemodynamics, Tubular Function and Vasoactive Hormones on Healthy Subjects

Healthy

Denmark
Regional Hospital Holstebro

Completed

Acute Effect of HMG-CoA Reductase Inhibition (Atorvastatin)on Renal Hemodynamics, Tubular Function and Vasoactive Hormones on Healthy Subjects

Healthy

Denmark
Rigshospitalet, Denmark

Unknown

Study of Renal Blood Flow During Human Endotoxemia

Healthy | Type 2 Diabetes | Endotoxemia

Denmark

Search clinical trials for: RPF

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Brazil

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations